Skip to content

 

Fellows Directory

David Baltimore

David Baltimore

Dr David Baltimore ForMemRS

Foreign Member


Elected: 1987

Biography

David Baltimore is a biologist who pioneered the development of DNA recombinant techniques, contributing to the discovery of how tumour viruses interact with the genetic material of cells. He shared the 1975 Nobel Prize in Physiology or Medicine for this work. David also helped to establish the US government’s guidelines on the Human Genome Project and is an advocate for research into HIV and AIDS.

In addition to recombinant DNA research, David has contributed to the fields of immunology, virology, cancer research and biotechnology. At the same time as Satoshi Mizutani and Howard Temin (with whom he shared the Nobel Prize), he independently discovered the reverse transcriptase enzyme — an essential component in the reproduction of retroviruses such as HIV.

In addition to his research, David is an influential administrator and public advocate for science and engineering. In collaboration with businessman and philanthropist Edwin ‘Jack’ Whitehead, he helped to set up the Whitehead Institute for Biomedical Research, an independent research institute allied with MIT that focuses on developmental biology.

Professional positions

President Emeritus & Professor of Biology, California Institute of Technology

Interest and expertise

Subject groups

  • Biochemistry and molecular cell biology
    • Molecular immunology
  • Microbiology, immunology and developmental biology
    • General microbiology (incl bacteriology and virology), Genetics (excluding population genetics)

Keywords

Gene therapy, Virology, MicroRNAs, Molecular Immunology, Tumor immunology

Awards

  • Nobel Prize in Physiology or Medicine

    Jointly with Renato Dulbecco and Howard Martin Temin for their discoveries concerning the interaction between tumour viruses and the genetic material of the cell.

Was this page useful?
Thank you for your feedback
Thank you for your feedback. Please help us improve this page by taking our short survey.